The surgical robotics maker posts better-than-expected quarterly earnings as it begins rollout of cardiac procedures.

Intuitive Surgical's 2025 earnings were strong, and the future remains bright, with valuation as the only big concern for investors.

This robotics company just put up another quarter of amazing growth, and the reasons to love the stock keep adding up.

Intuitive Surgical is a pure-play leader in robotic-assisted soft-tissue surgery. The company’s da Vinci platform is its foundational asset, supporting procedures across urology, gynecology, general ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) is among the most profitable healthcare stocks to buy. On January 26, TD Cowen began coverage on Intuitive Surgical, Inc. (NASDAQ:ISRG) with a Buy rating and a ...

Intuitive Surgical is a first-to-market leader in the field of surgical robotics. Medtronic is making headway with its own robot-assisted surgical system. Teradyne has a growing robotics segment and a ...

Intuitive Surgical ( ISRG) is scheduled to announce Q4 earnings results on Thursday, January 22nd, after market close. The ...

Intuitive Surgical (NASDAQ:ISRG) slipped about 5% in Wednesday trading after providing 2026 growth projections for its Da Vinci surgical systems that came slightly below analyst expectations. Warning!

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

Detailed price information for GE Healthcare Technologies Inc (GEHC-Q) from The Globe and Mail including charting and trades.